期刊
FRONTIERS IN BIOSCIENCE-LANDMARK
卷 9, 期 -, 页码 1889-1898出版社
FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/1388
关键词
pancreatic cancer; cell signaling; growth factors; growth factor receptors; TGF beta; review
资金
- NCI NIH HHS [CA96122] Funding Source: Medline
Pancreatic ductal adenocarcinomas continue to have the worst prognosis of any adult malignancy with a five-year survival rate of less than 4%. One approach to improve patient survival from pancreatic cancer is to identify new biological targets that contribute to the aggressive pathogenecity of this disease and to develop reagents that will interfere with the function of these targets. Apart from the identification of the genetic profile of pancreatic cancer, a number of studies have focused on aberrant cell signaling pathways and their role in pancreatic cancer biology and response to therapy. This review, although not comprehensive, will discuss the salient features of several of these pathways. These include the roles of TGFbeta signaling in both tumor suppression and tumor promotion and the effects of deregulation of phosphotyrosine kinase receptor signaling pathways in pancreatic cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据